Not for human or animal consumption, and not for medical, therapeutic, or diagnostic use
Semiglutide/Tirzepatide are injectable medications that aid in appetite suppression and weight loss
These patients are seeing endocrinologists or primary care physicians, but many endocrinologists are prescribing the GLP-1 therapies, and theyre very adept at screening because of the concern thats been raised
GLP-1 receptors are not just found in the pancreas and gutthey are also present in immune cells
Likewise, T cell exhaustion in breast cancer, especially in TNBC and HER2-positive types, is identified by a gradual decline in T cell functionality as a result of prolonged antigen exposure
Semaglutide GLP-1 was originally developed to treat type 2 diabetes, but it has also proven highly effective for weight management